Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 69.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealing Notification

18 Apr 2018 17:08

RNS Number : 3812L
NetScientific PLC
18 April 2018
 

18 April 2018

NetScientific plc

 

Directors Dealing Notification

 

NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation group, announces that on 17 April 2018 it received notification that Sir Richard Sykes, Barry Wilson, and Steve Smith (the "Directors"), subscribed for New Ordinary Shares (the "Shares") in the NetScientific Placing and Subscription (the "Placing") at a price of 52.5 pence per Share, with the Shares admitted to trading on AIM on 17 April 2018.

 

The details of the Directors' shareholdings in the Company following the Placing are as follows:

 

 

No. of Ordinary Shares as at 28 March 2018

(date of announcement of conditional Placing)

No. of New Ordinary Shares subscribed

No. of Ordinary Shares as at Admission

Percentage of enlarged share capital as at Admission

Sir Richard Sykes

62,500

30,952

93,452

0.12%

Barry Wilson

36,358

30,952

67,310

0.09%

Professor Stephen Smith

-

28,571

28,571

0.04%

 

The total number of voting rights in NetScientific is 78,561,866.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Sir Richard Sykes

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director - Chairman)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Barry Wilson

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Steve Smith

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 28,571

 

d)

 

Aggregated information

 

Aggregated volume

 

 28,571

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

For more information, please contact:

 

NetScientific plc

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800

Consilium Strategic Communications

Mary-Jane Elliott/Jessica Hodgson

Chris Welsh/Laura Thornton

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Bookrunner)

Jonathan Senior/David Arch/Ben Maddison

 Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Placing Agent)

David Parsons/Christopher Britton/Bidhi Bhoma/Euan Brown

Tel: +44 (0)20 3709 5700

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUAUCUPRGQR
Date   Source Headline
15th Jan 20207:00 amRNSBoard Change
18th Dec 201911:24 amRNSHolding(s) in Company
17th Dec 20193:04 pmRNSHolding(s) in Company
13th Dec 20191:21 pmRNSBoard Changes
21st Nov 20197:00 amRNSGlycotest receives 2nd $3m tranche of $10m finance
17th Oct 20192:14 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSAppointment to the Board
3rd Oct 20191:44 pmRNSPDS collaborates with Merck in Phase 2 studies
1st Oct 20192:10 pmRNSPDS prioritise PDS0101 in high risk HPV to Phase 2
19th Sep 20191:24 pmRNSPDS - positive data for immunotherapy treatment
19th Sep 201911:00 amRNSInterim Results for six months ended 30 June 2019
1st Aug 20191:44 pmRNSPDS second quarter 2019 financial results
31st Jul 20198:41 amRNSPDS Biotechnology Corp liquidity funding program
9th Jul 20192:58 pmRNSHolding(s) in Company
8th Jul 20194:04 pmRNSHolding(s) in Company
18th Jun 20192:27 pmRNSResult of Annual General Meeting
31st May 20197:00 amRNSPositive new data demonstrates NEATstiks potential
24th May 20199:50 amRNSNotice of AGM and Annual Report & Accounts
22nd May 20197:00 amRNSFull Year Results for the year ended 31 Dec 2018
16th May 20193:07 pmRNSPDS Biotechnology journal publication
25th Apr 20197:00 amRNSResignation of CEO
22nd Mar 20194:42 pmRNSSale of Wanda and Vortex
19th Mar 20197:00 amRNSPDS merger with Edge Therapeutics update
18th Mar 20192:09 pmRNSPDS completes merger with Edge Therapeutics
18th Mar 20192:07 pmRNSOrderly wind up of Wanda and Vortex
14th Mar 20197:00 amRNSShare Price Movement
4th Mar 201911:45 amRNSResults of General Meeting
1st Mar 201911:15 amRNSUpdate on upcoming General Meeting
27th Feb 20194:40 pmRNSSecond Price Monitoring Extn
27th Feb 20194:35 pmRNSPrice Monitoring Extension
27th Feb 20192:05 pmRNSSecond Price Monitoring Extn
27th Feb 20192:00 pmRNSPrice Monitoring Extension
25th Feb 201912:54 pmRNSHolding(s) in Company
21st Feb 20194:35 pmRNSHolding(s) in Company
20th Feb 201910:51 amRNSHolding(s) in Company
19th Feb 20192:06 pmRNSSecond Price Monitoring Extn
19th Feb 20192:00 pmRNSPrice Monitoring Extension
18th Feb 20194:54 pmRNSHolding(s) in Company
18th Feb 201911:06 amRNSSecond Price Monitoring Extn
18th Feb 201911:00 amRNSPrice Monitoring Extension
15th Feb 201912:00 pmRNSConclusion of Strategic Review
14th Feb 201912:07 pmRNSGlycotest Receives First $3m Tranche from Fosun
15th Jan 201911:08 amRNSTermination of Formal Sales Process
15th Jan 20199:37 amRNSForm 8.5 - NetScientific plc
14th Jan 201910:25 amRNSForm 8.5 - NetScientific PLC
8th Jan 201911:58 amRNSForm 8.5 - NetScientific PLC
7th Jan 201910:14 amRNSForm 8.5 - NetScientific PLC
4th Jan 20199:13 amRNSForm 8.5 - NetScientific PLC
31st Dec 20189:36 amRNSForm 8.5 - NetScientific PLC
24th Dec 201810:23 amRNSForm 8.5 - NetScientific PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.